FIELD: medicine; ophthalmology.
SUBSTANCE: group of inventions relates to the field of medicine, namely to ophthalmology, and is intended for the prevention and treatment of irritation and/or inflammation of the eye. The ophthalmic composition contains or consists of 0.10 – 0.45% by weight of hyaluronic acid and/or ophthalmologically acceptable hyaluronic acid salt, 0.60 – 5.00% by weight of ectoin or ophthalmologically acceptable ectoin derivative, as well as up to 100% by weight of water. In another embodiment, a method for preventing and treating irritation and/or inflammation of the eye is presented, including applying the specified composition to the eye from 1 to 10 times a day.
EFFECT: use of the group of inventions makes it possible to increase the viscosity of the composition due to the synergistic action of the components and, accordingly, to increase effectiveness of prevention and treatment of irritation and/or inflammation of the eye.
17 cl, 4 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
| REDUCED DOSAGE OF ANTIBIOTIC IN ANTIBIOTIC/ANTI-INFLAMMATORY AGENT COMPOSITIONS COMBINED FOR OPHTHALMIC USE | 2020 |
|
RU2820235C2 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2020 |
|
RU2795913C2 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2019 |
|
RU2792627C2 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION | 2013 |
|
RU2659207C2 |
| PHARMACEUTICAL COMPOSITION FOR TOPICAL USE FOR TREATMENT OF EYE AND NOSE ALLERGIC DISEASES | 1993 |
|
RU2130774C1 |
| OPHTHALMIC COMPOSITIONS CONTAINING COOPERATIVE COMPLEXES OF LOW- AND HIGH-MOLECULAR HYALURONIC ACID | 2016 |
|
RU2733733C2 |
| Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
| SOLUTION OF LIPOSOMAL EYE DROPS AND VARIANTS OF ITS APPLICATION FOR THE TREATMENT OF DRY EYE SYNDROME | 2019 |
|
RU2781131C1 |
